Skip to main content
Log in

Influence of complex solubility on formulations based on lambda carrageenan and basic drugs

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of the present work was to compare the behavior of some drug/carrageenan complexes having different solubility in water, in a controlled release formulation. Diltiazem HCl, bupropion HCl, metoprolol tartrate, and tramadol HCl were used as model drugs. The complexes were characterized by means of solubility measurements, release test at constant surface area, and water uptake measurements, and the results were related to their performance in controlled release formulations. For the more soluble complexes (involving metoprolol and tramadol) the occurrence of gelation after hydration was observed, while diltiazem complex apparently did not gellify; bupropion behavior was intermediate. A correspondence was found between the observed differences in complex solubility and hydration-gelation behavior and the drug release profiles. For all the drugs considered, the release was completed in about 10 to 12 hours, but different kinetics were observed depending on the solubility of the complexes. All the considered complexes seem suitable for controlled release purposes, although the data obtained show the relevance of the complex solubility to drug release profiles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kalinkova GN. Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations. Int J Pharm. 1999;187:1–15.

    Article  CAS  PubMed  Google Scholar 

  2. Nujoma YN, Kim C.J. A designer's polymer as an oral drug carrier (tablet) with pseudo-zero-order release kinetics. J Pharm Sci. 1996;85:1091–1095.

    Article  Google Scholar 

  3. Konar N, Kim C.J. Drug release from drug-polyanion complex tablets: poly(acrylomido-2-methyl-1-propanesulfonate sodium-co-methyl methacrylate). J Control Release. 1999;57:141–150.

    Article  CAS  PubMed  Google Scholar 

  4. FMC Corporation, Pharmaceutical Division, Philadelphia, PA, USA. Marine colloids carrageenan. Technical bulletin, 1993.

  5. Bonferoni MC, Rossi S, Tamayo M, Pedraz JL, Dominguez Gil A, Caramella C. On the employment of lambda carrageenan in a matrix system, I: sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum. J Control Release. 1993;26:119–127.

    Article  CAS  Google Scholar 

  6. Bonferoni MC, Rossi S, Ferrari F, Bertoni M, Bolhuis GK, Caramella C. On the employment of lambda carrageenan in a matrix system. III: optimization of a lambda carrageenan-HPMC hydrophilic matrix. J Control Release. 1998;51:231–239.

    Article  CAS  PubMed  Google Scholar 

  7. Bonferoni MC, Rossi S, Ferrari F, Bettinetti GP, Caramella C. Characterization of a diltiazem-lambda carrageenan complex. Int J Pharm. 2000;200:207–216.

    Article  CAS  PubMed  Google Scholar 

  8. Bonferoni MC, Rossi S, Ferrari F, Caramella C. Development of a once-a-day tablet formulation based on a diltiazem/carrageenan interaction product. In: Proceedings of the 2nd World Meeting APGI/APV. Paris. 25/28 May (1998). Pag 153–154.

  9. Caramella C, Bonferoni MC, Patent application PCT/EP/98/06864.

  10. Bonferoni MC, Rossi S. Ferrari F, Sorrenti M, Caramella C. Characterization of interaction products between carrageenan and some basic drugs. In: Proceedings of the 2nd World Meeting APGI/APV, Paris, 25/28 May (1998). Pag 71–72.

  11. Klotz IM, Walker FM, Pivan RB. The binding of organic ions by proteins. J Am Chem Soc. 1946;68:1486–1490.

    Article  CAS  PubMed  Google Scholar 

  12. Ferrari F, Rossi S, Bertoni M, Caramella C, Geddo M. Modelling of water penetration into fast disintegrating tablets. STP Pharma Sci. 1(2). (1991), 137–144.

    CAS  Google Scholar 

  13. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111.

    CAS  PubMed  Google Scholar 

  14. Bonferoni MC, Rossi S. Ferrari F, Stavik E, Pena Romero A, Caramella C. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS Pharm Sci Tech. 2000;1. Available at

  15. Bonferoni MC, Rossi S, Tamayo M, Pedraz JL, Dominguez Gil A. Caramella C. On the employment of lambda carrageenan in a matrix system. II: lambda carrageenan and hydroxypropylmethylcellulose mixtures. J Control Release. 1994;30:175–182.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carla Caramella.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aguzzi, C., Bonferoni, M.C., Fortich, M.R.O. et al. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs. AAPS PharmSciTech 3, 27 (2002). https://doi.org/10.1208/pt030327

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/pt030327

Keywords

Navigation